Michael Ballanger - EndoChoice Holdings Director

Director

Mr. Michael Ballanger is Director of the company. He is a graduate of Saint Louis University where he earned a bachelor of science in finance and a bachelor of arts in marketing before completing postgraduate work at the Wharton School of Finance. Mr. Ballanger has more than 30 years of experience as a junior mining and exploration specialist, as well as a solid background in corporate finance. Mr. Ballanger started his career at Mcleod Yonge Weir Ltd. Investment Dealers before moving onto new opportunities with Canaccord Capital Investment Dealers, and Richardson GMP Ltd. Investment Dealers. Mr. Ballanger now works for Bonaventure Explorations Ltd.Bonaventure Capital Corporationration Financial Consulting since 2018.
Tenure 6 years
Phone888-682-3636
Webhttp://www.endochoice.com
Ballanger years of experience have made him an industry veteran in mining and resource development.

EndoChoice Holdings Management Efficiency

The company has Return on Asset (ROA) of (0.473) % which means that for every 100 dollars spent on asset, it generated a loss of $0.473. This is way below average. EndoChoice Holdings' management efficiency ratios could be used to measure how well EndoChoice Holdings manages its routine affairs as well as how well it operates its assets and liabilities.
The company reports 42.64 M of total liabilities with total debt to equity ratio (D/E) of 0.7, which is normal for its line of buisiness. EndoChoice Holdings has a current ratio of 5.52, indicating that it is in good position to pay out its debt commitments in time. Debt can assist EndoChoice Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, EndoChoice Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like EndoChoice Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for EndoChoice to invest in growth at high rates of return. When we think about EndoChoice Holdings' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Gino DellomoFunko Inc
39
Frances RathkePlanet Fitness
61
Pierre LeComtePlanet Fitness
42
Robert JaffeFunko Inc
N/A
Cammie DunawayPlanet Fitness
58
Charles EssermanPlanet Fitness
57
Loudon OwenAcademy Sports OutdoorsInc
N/A
Scott SandellCoursera
56
Governor BensonPlanet Fitness
68
Chuck EssermanPlanet Fitness
55
Brian MariottiFunko Inc
56
Adam KrigerFunko Inc
51
Michael LaymanPlanet Fitness
32
Craig BensonPlanet Fitness
66
Diane IrvineFunko Inc
59
Edward WongPlanet Fitness
32
Jessica PihaGrafsteinFunko Inc
N/A
Karin IretonAcademy Sports OutdoorsInc
59
JeanGuy MartinAcademy Sports OutdoorsInc
N/A
Richard McNallyFunko Inc
61
Marc GrondahlPlanet Fitness
48
EndoChoice Holdings, Inc., a medical device company, designs and commercializes various solutions for gastrointestinal caregivers in the United States and internationally. EndoChoice Holdings (GI) is traded on New York Stock Exchange in USA and employs 501 people.

Management Performance

EndoChoice Holdings Leadership Team

Elected by the shareholders, the EndoChoice Holdings' board of directors comprises two types of representatives: EndoChoice Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EndoChoice. The board's role is to monitor EndoChoice Holdings' management team and ensure that shareholders' interests are well served. EndoChoice Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EndoChoice Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Simon MA, CFO
Scott Huennekens, Chairman of the Board
David Kaufman, Director
David Mowry, Director
Douglas Ladd, Chief Marketing Officer
Rurik Vandevenne, Director
Simon Tam, President CEO, Director
John Smyth, Director
James Balkcom, Director
Kevin Rubey, COO
Mark Gilreath, Founder, CEO and President and Director
Scott Davis, Director
Uri Geiger, Director
Scott Carter, Director
David Gill, CFO
Craig Walker, Director
William Enquist, Director
Michael Ballanger, Director
John Barr, Chairman of the Board, Interim CEO
Eric Schjelderup, Director

EndoChoice Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EndoChoice Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards EndoChoice Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, EndoChoice Holdings' short interest history, or implied volatility extrapolated from EndoChoice Holdings options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in EndoChoice Stock

If you are still planning to invest in EndoChoice Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EndoChoice Holdings' history and understand the potential risks before investing.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bonds Directory
Find actively traded corporate debentures issued by US companies
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device